Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Posted on by Innovator Awards

Dr. Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Shiraz University| Iran

Mohammad Sadegh Taghizadeh is based at the Agricultural Faculty of Shiraz University (Institute of Biotechnology, Shiraz-Isfahan Highway, Shiraz, Iran) where he pursues advanced research in bioactive small molecules and peptides—whether synthesised by ribosomes or derived from proteins. His work spans in vitro isolation, purification and structural-physicochemical characterisation of these compounds, their pharmacological and sensory properties, and complementary in silico design and target-interaction studies. He also explores recombinant production of bioactive peptides using plant and bacterial expression systems. Prior to his current role, he earned a bachelor’s in agricultural engineering (plant protection) at Shahid Bahonar University of Kerman, a master’s in plant biotechnology at University of Guilan (thesis: factors affecting virulence genes of Agrobacterium tumefaciens in Arabidopsis thaliana mutants), and a PhD in biotechnology at Shiraz University (dissertation: functional properties of bio-active peptides derived from plant resources). He gained research experience at the Medical University of Vienna (on discovery of a novel cyclotide targeting the CCK2 receptor) and later led a project on plant-derived bioinsecticides funded by the National Elite Foundation of Iran, while also teaching as a TA in plant genetic engineering, molecular markers and plant tissue culture at Shiraz University. His research has steadily contributed to the field of peptide biotechnology, with growing recognition: his h-index currently stands at (unknown) and his publication and citation counts are steadily rising as he continues to establish himself in the realm of bioactive small molecules and recombinant peptide production.

Profile: Orcid  |  Scopus 

Featured Publications 

Abbasi, A., Taghizadeh, M. S., Moghadam, A., Niazi, A., Lotfi, M., & Taghavi, S.-M. (2025). A comprehensive insight into ultrasound-assisted protein extraction from Camelina sativa and de-bittering of resulting hydrolysates with emphasis on their structural, physicochemical, sensory, and biological properties. Food Chemistry, 445, 145435.

Taghizadeh, M. S., Niazi, A., Mirzapour-Kouhdasht, A., Pereira, E. C., & Garcia-Vaquero, M. (2025). Enhancing cyclotide bioproduction: Harnessing biological synthesis methods and various expression systems for large-scale manufacturing. Critical Reviews in Biotechnology, 45(1), 1–20.

Hoseini, S., Moghadam, A., Palizban, A., Hoseini, F., Taghizadeh, M. S., Choopani, A., & Hoseini, F. (2025). Immune boosting by pharmaceutical C-phycocyanin, in vitro and in silico effects on peripheral blood mononuclear cells. Health Biotechnology and Biopharma, 8(1), 1–10.

Lotfi, M., Keshvari, T., Taghizadeh, M. S., Afsharifar, A., Moghadam, A., Aram, F., & Niazi, A. (2025). Optimizing Camelina sativa oil extraction and its cytotoxicity using RSM by emphasis on antioxidant properties, physical characteristics, and molecular docking insights. Industrial Crops and Products, 215, 120334.

Taghizadeh, M. S., Mirzapour-Kouhdasht, A., & Huang, J.-Y. (2025, December). Unraveling the structure-activity relationship and molecular mechanisms for targeted therapeutic applications of food-derived angiotensin-I-converting enzyme inhibitory peptides. Food Bioscience, 65, 107820.

Prof. Zhiguo Wang – Polypharmacology – Outstanding Scientist Award

Posted on by Innovator Awards

Prof. Zhiguo Wang - Polypharmacology - Outstanding Scientist Award

Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Bidirectional Complications among Chronic Conditions, Jinan University, China - China 

Author Profile

SCOPUS 

ORCID

GOOGLE SCHOLAR

Early academic pursuits 🎓

Zhiguo Wang embarked on his academic journey with a strong foundation in pharmacology, pursuing his studies at Harbin Medical University in Heilongjiang, China. His early work laid the groundwork for a distinguished career focused on understanding chronic diseases and their complex interrelations. His rigorous training and commitment to research established him as a formidable scholar in the field of cardiovascular and chronic disease research.

Professional endeavors 🏢

Throughout his career, Zhiguo has held numerous prestigious positions, demonstrating his leadership in the medical and research communities. He is currently the Director and Professor at the Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Chronic Disease Complex Complications at Jinan University in Guangzhou, China. His role as a chief scientist and professor across various departments at the First Affiliated Hospital of Jinan University reflects his multifaceted expertise. Additionally, he has contributed significantly as a Distinguished Professor at Harbin Medical University and held a visiting professorship at the Montreal Heart Institute in Canada.

Contributions and research focus 🔬

Zhiguo's research focuses on the mechanistic and translational aspects of chronic diseases, particularly the bidirectional complications arising from these conditions. He has pioneered studies that explore the pathophysiology of cardiovascular diseases and their links to metabolic disorders. His work employs innovative Polypharmacology methodologies to investigate the underlying mechanisms of disease progression and to develop effective therapeutic strategies, aiming to improve patient outcomes in chronic disease management.

Accolades and recognition 🏅

Zhiguo Wang has received numerous accolades for his contributions to medical research, including being a Fellow of the American Heart Association (FAHA) and a Polypharmacology Fellow of the European Society of Cardiology (FESC). His recognition as a Marion L. Munro Research Scholar by the Canadian Diabetes Association further underscores his impactful research in chronic disease mechanisms. His extensive publication record in high-impact journals reflects his influence and standing in the academic community.

Impact and influence 🌍

Zhiguo's research has made a significant impact on the understanding of chronic diseases and their complications, influencing both clinical practice and public health strategies. His work is instrumental in bridging the gap between basic science and clinical applications, ultimately contributing to improved therapeutic approaches Polypharmacology for patients suffering from chronic conditions. He is a sought-after speaker and mentor, inspiring the next generation of researchers in his field.

Legacy and future contributions 🔮

As a leader in chronic disease research, Zhiguo Wang’s legacy is built on his commitment to advancing scientific knowledge and improving patient care. His ongoing research aims to unravel the complexities of chronic disease interactions and to foster innovative therapeutic strategies. With a focus on translational research, Zhiguo's future contributions are poised to drive significant advancements in understanding and treating chronic conditions, leaving a lasting impact on the field and enhancing healthcare outcomes globally.

Notable Publications 

Topical GDF11 accelerates skin wound healing in both type 1 and 2 diabetic mouse models  2020(9)

Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current 2020(8)

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis 2020(38)

Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice 2019(22)

Systematic analysis of intestinal microRNAs expression in HCC: Identification of suitable reference genes in fecal samples 2019(4)

Dr. Vikas Shukla – Nanomedicine and Immunology – Best Researcher Award

Posted on by Innovator Awards

Dr. Vikas Shukla - Nanomedicine and Immunology - Best Researcher Award

AIIMS, New Delhi - India 

Author Profile

GOOGLE SCHOLAR 

Early academic pursuits 📚

Vikas Shukla's academic journey began with a deep-rooted passion for nanobiotechnology and immunology. He dedicated himself to gaining a solid foundation in the life sciences, eventually leading him to pursue advanced studies in these cutting-edge fields. His education, characterized by rigorous training, provided the tools necessary for his future contributions to scientific research. Over the years, vikas built an impressive knowledge base in bacterial culture, cell culture, and immunoassays, which would serve as the backbone of his research career.

Professional endeavors 🏢

currently serving as a research scientist-II at the all india institute of medical sciences (aiims) in new delhi, india, vikas brings over 8 years of extensive experience to the forefront. His role at aiims, within the department of plastic, reconstructive & burns surgery, involves not only laboratory-based research but also project management. This balance between hands-on science and overseeing project timelines ensures that he contributes effectively to the scientific and clinical goals of his department.

Contributions and research focus 🔬

Vikas's research primarily revolves around nanobiotechnology and immunology, with a keen focus on innovative solutions in medical science. He has demonstrated exceptional expertise in bacterial culture, cell culture, immunoassays, and small animal handling. His work seeks to bridge the gap between complex scientific Nanomedicine and Immunology theories and their real-world applications, particularly in healthcare. Vikas’s research outputs have helped advance understanding in both fundamental immunological responses and the application of nanotechnology in therapeutic treatments.

Accolades and recognition 🏅

throughout his career, vikas has received commendations for his meticulous work and contributions to the field. His ability to keep projects both on time and on Nanomedicine and Immunology budget while maintaining high scientific standards has not gone unnoticed. He is widely recognized among his peers and colleagues for his diligence, precision, and ability to translate complex scientific concepts into more accessible knowledge. His exceptional communication skills have further bolstered his reputation as a skilled researcher and project manager.

Impact and influence 🌍

Vikas’s research holds significant implications for the fields of immunology and nanobiotechnology, particularly within clinical settings. His work on developing innovative medical treatments and enhancing immunological responses has the potential to save lives and improve patient outcomes. His influence extends beyond the laboratory, as his project management skills ensure that critical research is completed efficiently, benefiting both the scientific community and society as a whole.

Legacy and future contributions 🔮

looking ahead, Vikas Shukla’s legacy will likely be defined by his contributions to advancing the use of nanotechnology in medicine. His ongoing work at aiims and within the broader scientific community will continue to impact the development of new therapeutic approaches and enhance our understanding of immune Nanomedicine and Immunology responses. His commitment to pushing the boundaries of science while managing complex projects ensures that his influence will be felt for years to come.

Notable Publications 

Smart Drug-Delivery Systems in the Treatment of Rheumatoid Arthritis: Current, Future Perspectives  2021

Dynamic light scattering (DLS) particle size analysis for biomedical nanotechnology  2023

Downmodulation of lysophosphatidic acid by Berberine loaded folate-conjugated glycol chitosan nanoparticles  2022

Therapeutic use of mesenchymal stem cells against SARS-Cov-2: present and future prospects  2022

Phytomedicine Meets Nanotechnology: A Cellular Approach to Rheumatoid Arthritis Treatment 2024